Landmark Study: Autism Recognized as Medically Treatable

[Guest guest]

Hundreds of Local Autism EventsRESEARCHLandmark Study: Autism Recognized As Medically Treatable In April of 2008, the American College of Medical Genetics (ACMG), an AMA- recognized board, issued clinical practice guidelines that clinical geneticists should follow in determining the etiology for those with an autistic spectrum disorder (ASD) diagnosis and in treating patients with this diagnosis. This study, “Autism spectrum disorder-associated biomarkers for case evaluation and management by clinical geneticists” in Expert Review of Molecular Diagnostics,1 confirms that there are now well- established, routine, clinically available, identified biomarkers to help clinical geneticists medically evaluate and treat individuals diagnosed with an ASD and briefly outlines some recognized biomarkers. Depending on the cause of the ASD, these researchers have found that “associated medical risks may be identified, which may lead to screening and potential morbidity prevention in patients and other family members.” The non-profit CoMeD, Inc., and, through a grant from the Brenen Hornstein Autism Research & Education (BHARE) Foundation, the non-profit Institute of Chronic Illnesses, Inc. funded this research study. The important clinical tools identified for medical evaluation and treatment response monitoring included: • Pophyrin biomarkers – to help determine if mercury toxicity is present, and, when it is found, to monitor changes in mercury-burden during detoxification therapies. • Trans-Sulfuration biomarkers – to help determine if mercury biochemical susceptibility is present and, when it is found, to monitor patient response during supplementation with nutritional therapies such as methylcobalamin (the methyl form of vitamin B12), folinic acid, and pyroxidine (vitamin B6). • Oxidative Stress/Inflammation biomarkers – to help determine if there are excessive by-products of metabolic pathways, and, when they are found, to monitor patient progress during supplementation with anti-inflammatory drugs such as Aldactone® (spironolactone). • Hormonal biomarkers – to help determine if hormonal abnormalities are present and, when they are found, to monitor patient progress during the indicated treatment with hormonal regulation drugs such as Lupron® (leuprolide acetate) and Yaz® (drospirenone/ethynyl estradiol). • Mitochondrial Dysfunction biomarkers – to help determine if there are disruptions in the energy production pathways, and, when they are found, to monitor patient progress during supplementation with drugs such as Carnitor® (L-carnitine). • Genetic biomarkers – to help determine if For rest of today's SAR click here:www.sarnet.org/frm/forsar.htm Today's SAR is provided through the support of paid subscription readers. - THANK YOU -

$35 for 1 year - or free!www.sarnet.org

Copyright Notice: The above items are copyright protected. They are for our readers' personal education or research purposes only and provided at their request. Articles may not be further reprinted or used commercially without consent from the copyright holders. To find the copyright holders, follow the referenced website link provided at the beginning of each item.

Lenny Schafer editor@... The Schafer Autism Report is a non-profit corporation

Vol. 12 No. 172p Unsubscribe here: www.sarnet.org/frm/unsub2.htm

-----Inline Attachment Follows-----

_______________________________________________SARnets mailing listSARnets@...http://lists.igc.org/mailman/listinfo/sarnetsYou can unsubscribe send email:http://www.sarnet.org/frm/unsub2.htm-- You are subscribed as: loisnoland@...

hasEML = false;

Move...

Go to Previous message | Go to Next message | Back to Messages

Select Message Encoding ASCII (ASCII)Greek (ISO-8859-7)Greek (Windows-1253)Latin-10 (ISO-8859-16)Latin-3 (ISO-8859-3)Latin-6 (ISO-8859-10)Latin-7 (ISO-8859-13)Latin-8 (ISO-8859-14)Latin-9 (ISO-8859-15)W. European (850)W. European (CP858)W. European (HPROMAN8)W. European (MACROMAN8)W. European (Windows-1252)Armenia (ARMSCII-8)Baltic Rim (ISO-8859-4)Baltic Rim (WINDOWS-1257)Cyrillic (866)Cyrillic (ISO-8859-5)Cyrillic (KOI8-R)Cyrillic (KOI8-RU)Cyrillic (KOI8-T)Cyrillic (KOI8-U)Cyrillic (WINDOWS-1251)Latin-2 (852)Latin-2 (ISO-8859-2)Latin-2 (WINDOWS-1250)Turkish (ISO-8859-9)Turkish (WINDOWS-1254)Arabic (ISO-8859-6, ASMO-708)Arabic (WINDOWS-1256)Hebrew (856)Hebrew (862)Hebrew (WINDOWS-1255)Chinese Simplified (GB-2312-80)Chinese Simplified (GB18030)Chinese Simplified (HZ-GB-2312)Chinese Simplified (ISO-2022-CN)Chinese Simplified (WINDOWS-936)Chinese Trad.-Hong Kong (BIG5-HKSCS)Chinese Traditional (BIG5)Chinese Traditional (EUC-TW)Japanese (SHIFT_JIS)Japanese (EUC-JP)Japanese (ISO-2022-JP)Korean (ISO-2022-KR)Korean (EUC-KR)Thai (TIS-620-2533)Thai (WINDOWS-874)Vietnamese (TCVN-5712)Vietnamese (VISCII)Vietnamese (WINDOWS-1258)Unicode (UTF-7)Unicode (UTF-8)Unicode (UTF-16)Unicode (UTF-32) | Full Headers

Search Mail

Search the Web

gLaunchProfile.stop("T5");

var frmWarnMsg = 'Warning! You are about to send information to someone other than Yahoo! If you do not want anyone outside of Yahoo! to have this information, click \"Cancel\" now.';

frmWarnMsg += '\n' + 'Remember: Yahoo! will NEVER ask you for your password in an unsolicited phone call or an unsolicited email.';

var pwdWarnShown = 'false';

var pwdWarnMsg = 'Warning! You are about to enter a password in a form that will not be sent to Yahoo!.';

pwdWarnMsg += '\n' + 'Remember: Yahoo! will NEVER ask you for your password in an unsolicited phone call or an unsolicited email.';

var lnkWarnMsg = 'Warning! It appears that you are about to access a website that has non-standard web address format.';

lnkWarnMsg += ' ' + 'Such sites may contain harmful entities such as viruses.';

lnkWarnMsg += ' ' + 'We recommend you use extreme caution.';

var theMainWindow = {

showFormWarning: function(msgFrm) {

return confirm(frmWarnMsg);

},

showPasswordWarning: function(msgFrm) {

if (pwdWarnShown == 'false') {

pwdWarnShown = 'true';

alert(pwdWarnMsg);

}

},

showLinkWarning: function(msgFrm) {

return confirm(lnkWarnMsg);

}

};

function fallBack() {

var msgBody = document.getElementById("message1920932332");

if (msgBody) {

document.getElementById("top_move_select1920932332").style.visibility = document.getElementById("bottom_move_select1920932332").style.visibility = msgBody.style.overflow = msgBody.style.visibility = "visible";

}

var showFolderForm = document.getElementById("showFolderForm");

if (showFolderForm) {

showFolderForm.className += " show"; }

var composeArea = document.getElementById("composeArea");

if (composeArea) {

composeArea.style.display = document.getElementById("bccid").style.display = "block";

document.getElementById("hideBcc").style.display = "none";

document.getElementById("insert_address").className = "nojs";

}

}

if (typeof YAHOO == "undefined" || typeof YAHOO.mc == "undefined") {

if (window.addEventListener) {

window.addEventListener("load", fallBack, false);

} else if (window.attachEvent) {

window.attachEvent("onload", fallBack);

} else {

window.onload = fallBack; }

}

gLaunchProfile.start("adLoadTime");

if(window.yzq_d==null)window.yzq_d=new Object();

window.yzq_d['5OmzPdG_XLY-']='&U=12al0hfrg%2fN%3d5OmzPdG_XLY-%2fC%3d-1%2fD%3dRS%2fB%3d-1%2fV%3d0';

if(window.yzq_d==null)window.yzq_d=new Object();

window.yzq_d['5emzPdG_XLY-']='&U=12bcgr7uo%2fN%3d5emzPdG_XLY-%2fC%3d-2%2fD%3dRS2%2fB%3d-2%2fV%3d0';

Copyright © 1994-2008 Yahoo! Inc. All rights reserved. Terms of Service - Copyright/IP Policy - GuidelinesNOTICE: We collect personal information on this site.To learn more about how we use your information, see our Privacy

Lois Noland Always in search for the "cure"

Lois NolandI don't give inI don't give upAnd I don't take no for an answerAlways looking for the "Cure"

I don't give inI don't give upAnd I don't take NO for an answer.

If God Brings you to it,He will Bring you though it.